Jeremy Grantham's OGN Position Overview
Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 494,047 shares of Organon & Co. (OGN) worth $5.28 M, representing 0.01% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Jeremy Grantham has maintained a strategic position in OGN, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 388,060 shares. Largest reduction occurred in Q4 2023, reducing 275,062 shares.
Analysis based on 13F filings available since 2013 Q2
Jeremy Grantham's Organon & Co (OGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Organon & Co (OGN) Trades by Jeremy Grantham
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2021 | +315,462 | New Buy | 315,462 | $30.26 |
| Q3 2021 | -20,153 | Reduce 6.39% | 295,309 | $32.79 |
| Q4 2021 | -295,309 | Sold Out | 295,309 | $0.00 |
| Q4 2023 | +20,247 | New Buy | 20,247 | $14.42 |
| Q1 2024 | +10,148 | Add 50.12% | 30,395 | $18.80 |
| Q2 2024 | -8,690 | Reduce 28.59% | 21,705 | $20.70 |
| Q3 2024 | +6,941 | Add 31.98% | 28,646 | $19.13 |
| Q4 2024 | -28,646 | Sold Out | 28,646 | $0.00 |
| Q1 2025 | +416,706 | New Buy | 416,706 | $14.89 |
| Q2 2025 | +108,429 | Add 26.02% | 525,135 | $9.68 |
| Q3 2025 | -31,088 | Reduce 5.92% | 494,047 | $10.68 |
Jeremy Grantham's Organon & Co Investment FAQs
Jeremy Grantham first purchased Organon & Co. (OGN) in Q2 2021, acquiring 315,462 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham has held Organon & Co. (OGN) for 18 quarters since Q2 2021. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham's largest addition to Organon & Co. (OGN) was in Q1 2025, adding 416,706 shares worth $6.2 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 494,047 shares of Organon & Co. (OGN), valued at approximately $5.28 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Organon & Co. (OGN) represents approximately 0.01% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham's peak holding in Organon & Co. (OGN) was 525,135 shares, as reported at the end of Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.